Rotavirus vaccines: current prospects and future challenges
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kosek, 2003, The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000, Bull World Health Organ, 81, 197
Black, 2003, Where and why are 10 million children dying every year?, Lancet, 361, 2226, 10.1016/S0140-6736(03)13779-8
2005
Bresee, 2004, First report from the Asian Rotavirus Surveillance Network, Emerg Infect Dis, 10, 988, 10.3201/eid1006.030519
Cunliffe, 1998, Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization, Bull World Health Organ, 76, 525
Kane, 2004, The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines, Rev Panam Salud Publica, 16, 371, 10.1590/S1020-49892004001200002
Parashar, 2003, Global illness and deaths caused by rotavirus disease in children, Emerg Infect Dis, 9, 565, 10.3201/eid0905.020562
Parashar, 2005, Rotavirus and severe childhood diarrhea, Emerg Infect Dis, 12, 304, 10.3201/eid1202.050006
Clark, 2004, Rotavirus vaccines, 1327
Glass, 2005, Rotavirus vaccines: targeting the developing world, J Infect Dis, 192, S160, 10.1086/431504
Cook, 1990, Global seasonality of rotavirus infections, Bull World Health Organ, 68, 171
Villa, 1999, Seasonal diarrrhoeal mortality among Mexican children, Bull World Health Organ, 77, 375
Parashar, 2003, The global burden of diarrhoeal disease in children, Bull World Health Organ, 81, 236
Lynch, 2003, The pathology of rotavirus-associated deaths, using new molecular diagnostics, Clin Infect Dis, 37, 1327, 10.1086/379322
Morrison, 2001, Histologic distribution of fatal rotaviral infection: an immunohistochemical and reverse transcriptase in situ polymerase chain reaction analysis, Hum Pathol, 32, 216, 10.1053/hupa.2001.21565
Carlson, 1978, Fatal rotavirus gastroenteritis: an analysis of 21 cases, Am J Dis Child, 132, 477, 10.1001/archpedi.1978.02120300037006
Kapikian, 2001, Rotaviruses, 1787
Estes, 2001, Rotaviruses and their replication, 1747
Ball, 1996, Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein, Science, 272, 101, 10.1126/science.272.5258.101
Blutt, 2003, Rotavirus antigenaemia and viraemia: a common event?, Lancet, 362, 1445, 10.1016/S0140-6736(03)14687-9
Fischer, 2005, Rotavirus antigenemia in patients with acute gastroenteritis, J Infect Dis, 192, 913, 10.1086/432549
Gilger, 1992, Extraintestinal rotavirus infections in children with immunodeficiency, J Pediatr, 120, 912, 10.1016/S0022-3476(05)81959-6
Lynch, 2001, Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review, Clin Infect Dis, 33, 932, 10.1086/322650
Pang, 1996, Detection of rotavirus RNA in cerebrospinal fluid in a case of rotavirus gastroenteritis with febrile seizures, Pediatr Infect Dis J, 15, 543, 10.1097/00006454-199606000-00015
Ushijima, 1994, Detection and sequencing of rotavirus VP7 gene from human materials (stools, sera, cerbrospinal fluids, and throat swabs) by reverse transcription and PCR, J Clin Microbiol, 32, 2893, 10.1128/JCM.32.12.2893-2897.1994
Cicirello, 1994, High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus, Pediatr Infect Dis J, 13, 720, 10.1097/00006454-199408000-00008
Kilgore, 1996, Neonatal rotavirus infection in Bangladesh: strain characterization and risk factors for nosocomial infection, Pediatr Infect Dis J, 15, 672, 10.1097/00006454-199608000-00007
Omoigberale, 1995, Nosocomial rotavirus infection in newborns, East Afr Med J, 72, 220
Bishop, 1983, Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children, N Engl J Med, 309, 72, 10.1056/NEJM198307143090203
Velazquez, 1993, Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infections in Mexican children, Pediatr Infect Dis J, 12, 54, 10.1097/00006454-199301000-00012
Gentsch, 2005, Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs, J Infect Dis, 192, S146, 10.1086/431499
Cunliffe, 2002, The expanding diversity of rotaviruses, Lancet, 359, 640, 10.1016/S0140-6736(02)07781-4
Desselberger, 2001, Rotavirus epidemiology and surveillance, Novartis Found Symp, 238, 125, 10.1002/0470846534.ch9
Koshimura, 2000, The relative frequencies of G serotypes of rotaviruses recovered from hospitalized children with diarrhea: a 10-year survey (1987–1996) in Japan with a review of globally collected data, Microbiol Immunol, 44, 499, 10.1111/j.1348-0421.2000.tb02525.x
Santos, 2005, Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine, Rev Med Virol, 15, 29, 10.1002/rmv.448
Iturriza-Gomara, 2000, Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998, J Clin Microbiol, 38, 4394, 10.1128/JCM.38.12.4394-4401.2000
Ramachandran, 1996, Unusual diversity of human rotavirus G and P genotypes in India, J Clin Microbiol, 34, 436, 10.1128/JCM.34.2.436-439.1996
Kang, 2005, Epidemiologic profile of rotaviral infection in India: challenges for the 21st century, J Infect Dis, 192, S120, 10.1086/431496
Greenberg, 1981, Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine reassortant, Proc Natl Acad Sci USA, 78, 420, 10.1073/pnas.78.1.420
Kapikian, 1996, Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children, J Infect Dis, 174, S65, 10.1093/infdis/174.Supplement_1.S65
Clark, 1996, WC3 reassortant vaccines in children, Arch Virol, 12, 187
Clements-Mann, 1999, Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3, or 4 in adults, children and infants, Vaccine, 17, 2715, 10.1016/S0264-410X(98)00497-6
2000, 1
2000
Bhan, 1993, Protection conferred by neonatal rotavirus infection against subsequent diarrhea, J Infect Dis, 168, 282, 10.1093/infdis/168.2.282
Velazquez, 1996, Rotavirus infection in infants as protection against subsequent infections, N Engl J Med, 335, 1022, 10.1056/NEJM199610033351404
Grimwood, 1988, Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children, J Clin Microbiol, 26, 732, 10.1128/JCM.26.4.732-738.1988
Jiang, 2002, The role of serum antibodies in the protection against rotavirus disease: an overview, Clin Infect Dis, 34, 1351, 10.1086/340103
Ward, 1995, Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines, Vaccine, 13, 1226, 10.1016/0264-410X(95)00060-E
Westerman, 2005, Serum IgG mediates mucosal immunity against rotavirus infection, Proc Natl Acad Sci USA, 102, 7268, 10.1073/pnas.0502437102
1986, The prospects of immunizing against rotavirus, 308
Bresee, 1999, Current status and future priorities for rotavirus vaccine development, evaluation, and implementation in developing countries, Vaccine, 17, 2207, 10.1016/S0264-410X(98)00376-4
Vesikari, 1984, Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine, Lancet, 1, 977, 10.1016/S0140-6736(84)92323-7
1999, Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children, MMWR Morb Mortal Wkly Rep, 48, 1
Perez-Schael, 1997, Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela, N Engl J Med, 337, 1181, 10.1056/NEJM199710233371701
Bernstein, 1995, Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children, JAMA, 273, 1191, 10.1001/jama.1995.03520390051032
Rennels, 1996, Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: report of the national multicenter trial, Pediatrics, 97, 7
Smith, 2003, The first oral rotavirus vaccine, 1998–1999: estimates of uptake from the National Immunization Survey, Public Health Rep, 118, 134, 10.1093/phr/118.2.134
Peter, 2002, Intussusception, rotavirus, and oral vaccines: summary of a workshop, Pediatrics, 110, e67, 10.1542/peds.110.6.e67
1999, Intussusception among recipients of rotavirus vaccine, United States, 1998–1999, MMWR Morb Mortal Wkly Rep, 48, 577
1999, Withdrawal of rotavirus vaccine recommendation, MMWR Morb Mortal Wkly Rep, 48, 1007
Simonsen, 2001, Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception, Lancet, 358, 1224, 10.1016/S0140-6736(01)06346-2
Chang, 2001, Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state, Pediatrics, 108, 54, 10.1542/peds.108.1.54
Murphy, 2003, Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions, J Infect Dis, 187, 1301, 10.1086/367895
Murphy, 2001, Intussusception among infants given an oral rotavirus vaccine, N Engl J Med, 344, 564, 10.1056/NEJM200102223440804
Simonsen, 2005, More on RotaShield and intussusception: the role of age at the time of vaccination, J Infect Dis, 192, S36, 10.1086/431512
Parashar, 2000, Trends in intussusception-associated hospitalizations and deaths among US infants, Pediatrics, 106, 1413, 10.1542/peds.106.6.1413
Heaton, 2005, Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis, J Infect Dis, 192, S17, 10.1086/431500
Phua, 2005, Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled Phase 2 trial involving 2464 Singaporean infants, J Infect Dis, 192, S6, 10.1086/431511
De Vos, 2004, A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis, Pediatr Infect Dis J, 23, S179, 10.1097/01.inf.0000142370.16514.4a
Bernstein, 1999, Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial, Lancet, 354, 287, 10.1016/S0140-6736(98)12106-2
Vesikari, 2004, Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants, Vaccine, 22, 2836, 10.1016/j.vaccine.2004.01.044
Vesikari, 2004, Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants, Pediatr Infect Dis J, 23, 937, 10.1097/01.inf.0000141722.10130.50
Linhares, 2005, A short report on highlights of world-wide development of RIX4414: a Latin American experience, Vaccine
Salinas, 2005, Evaluation of safety, immunogenicity and efficacy of an attentuated rotavirus vaccine, RIX 4414: a randomized, placebo controlled trial in Latin American infants, Pediatr Infect Dis J, 24, 807, 10.1097/01.inf.0000178294.13954.a1
Ruiz-Palacios, 2006, Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis, N Engl J Med, 354, 11, 10.1056/NEJMoa052434
Macias M, Lopez P, Velazquez FR, et al. The rotavirus vaccine RIX 4414 (Rotarix) is not associated with intussusception in one year old infants. Interscience Conference on Antimicrobial Agents and Chemotherapy, Dec 16–19, 2005. Washington DC, Poster No. G−841.
Clark, 1996, The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants, J Infect Dis, 174, S73, 10.1093/infdis/174.Supplement_1.S73
Clark, 1988, Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season, J Infect Dis, 158, 570, 10.1093/infdis/158.3.570
Bernstein, 1990, Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants, J Infect Dis, 162, 1055, 10.1093/infdis/162.5.1055
Georges-Courbot, 1991, Evaluation of the effiacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa, Res Virol, 142, 405, 10.1016/0923-2516(91)90008-Q
Clark, 2003, Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation, Pediatric Infect Dis J, 22, 914, 10.1097/01.inf.0000091887.48999.77
Vesikari, 2006, Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine, N Engl J Med, 354, 23, 10.1056/NEJMoa052664
Das, 1993, Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E, Virology, 197, 99, 10.1006/viro.1993.1570
Glass, 2005, Development of candidate rotavirus vaccines derived from neonatal strains in India, J Infect Dis, 192, S30, 10.1086/431498
Vethanayagam, 2004, Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988–1999, J Infect Dis, 189, 2282, 10.1086/420889
Barnes, 1997, Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate, J Paediatr Child Health, 33, 300, 10.1111/j.1440-1754.1997.tb01604.x
Barnes, 2002, Early phase II trial of human rotavirus vaccine candidate RV3, Vaccine, 20, 2950, 10.1016/S0264-410X(02)00235-9
Kapikian, 2005, A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception, J Infect Dis, 192, S22, 10.1086/431510
Ciarlet, 1998, Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity, J Virol, 72, 9233, 10.1128/JVI.72.11.9233-9246.1998
Jiang, 1999, Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles, Vaccine, 17, 1005, 10.1016/S0264-410X(98)00317-X
Estes, 1997, Virus-like particle vaccines for mucosal immunization, 387
Choi, 2004, Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice, Protein Expr Purif, 38, 205, 10.1016/j.pep.2004.08.009
Herrmann, 1996, Protection against rotavirus infections by DNA vaccination, J Infect Dis, 174, S93, 10.1093/infdis/174.Supplement_1.S93
Coffin, 1995, Induction of virus-specific antibody production by lamina propria lymphocytes following intramuscular inoculation with rotavirus, J Infect Dis, 172, 874, 10.1093/infdis/172.3.874
Conner, 1993, Rotavirus vaccine administered parenterally induces protective immunity, J Virol, 67, 6633, 10.1128/JVI.67.11.6633-6641.1993
De Mol, 1980, Failure of live, attenuated oral rotavirus vaccine, Lancet, 2, 108
Hanlon, 1987, Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants, Lancet, 1, 1342, 10.1016/S0140-6736(87)90649-0
Lanata, 1996, Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru, J Infect Dis, 174, 268, 10.1093/infdis/174.2.268
Lanata, 1996, Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru, Vaccine, 14, 237, 10.1016/0264-410X(95)00132-K
Lanata, 1989, Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine, J Infect Dis, 159, 452, 10.1093/infdis/159.3.452
Linhares, 1996, Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine Belem, Brazil, Bull World Health Organ, 74, 491
Glass, 1999, Commentary: reanalysis of the results of two rotavirus vaccine trials: an appraisal of the reappraisal, Ped Infect Dis J, 18, 1006, 10.1097/00006454-199911000-00014
2004
Clemens, 2005, Introducing new vaccines into developing countries: obstacles, opportunities and complexities, Nat Med, 11, S12, 10.1038/nm1225
Steele, 2003, Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa, Vaccine, 21, 354, 10.1016/S0264-410X(02)00615-1
2002, 1
Bresee, 2005, Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines, J Infect Dis, 192, S1, 10.1086/431515